Uncategorized
NovaBay Pharmaceuticals to Distribute Zocular® Dry Eye Products
EMERYVILLE, Calif. & CYPRESS, Texas--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova for the eye care market, announces an agreement with Okra Limited to distribute their Zocular dry eye products alongside Avenova in NovaBay’s physician-dispensed sales channel. Products sold under the Zocular brand were developed by Okra Limited CEO Peter Pham, MD, a board-certified ophthalmologist, and are all complementary to A